- Home
- AQST vs EFR Comparison
AQST vs EFR Comparison
Compare AQST & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- EFR
- Stock Information
- Founded
- AQST 2004
- EFR 2003
- Country
- AQST United States
- EFR United States
- Employees
- AQST N/A
- EFR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- EFR Trusts Except Educational Religious and Charitable
- Sector
- AQST Health Care
- EFR Finance
- Exchange
- AQST Nasdaq
- EFR Nasdaq
- Market Cap
- AQST 390.4M
- EFR 344.0M
- IPO Year
- AQST 2018
- EFR N/A
- Fundamental
- Price
- AQST $3.77
- EFR $11.71
- Analyst Decision
- AQST Strong Buy
- EFR
- Analyst Count
- AQST 6
- EFR 0
- Target Price
- AQST $10.67
- EFR N/A
- AVG Volume (30 Days)
- AQST 1.4M
- EFR 88.6K
- Earning Date
- AQST 08-11-2025
- EFR 01-01-0001
- Dividend Yield
- AQST N/A
- EFR 9.43%
- EPS Growth
- AQST N/A
- EFR N/A
- EPS
- AQST N/A
- EFR 1.69
- Revenue
- AQST $44,132,000.00
- EFR N/A
- Revenue This Year
- AQST N/A
- EFR N/A
- Revenue Next Year
- AQST $38.71
- EFR N/A
- P/E Ratio
- AQST N/A
- EFR $7.74
- Revenue Growth
- AQST N/A
- EFR N/A
- 52 Week Low
- AQST $2.12
- EFR $10.95
- 52 Week High
- AQST $5.80
- EFR $13.29
- Technical
- Relative Strength Index (RSI)
- AQST 44.00
- EFR 43.60
- Support Level
- AQST $3.85
- EFR $11.64
- Resistance Level
- AQST $4.13
- EFR $11.79
- Average True Range (ATR)
- AQST 0.25
- EFR 0.09
- MACD
- AQST -0.03
- EFR 0.01
- Stochastic Oscillator
- AQST 13.79
- EFR 60.00
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.